Cite

HARVARD Citation

    Silverberg, J. et al. (n.d.). 339 Dupilumab 16-week efficacy and safety are robust and consistent in adults over 60 years of age with moderate-to-severe atopic dermatitis. British journal of dermatology. p. . [Online]. 
  
Back to record